Universidad Central de Venezuela-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2007

  1. Evaluation of the anti-inflammatory and analgesic activity of Me-UCH9, a dual cyclooxygenase-2/5-lipoxygenase inhibitor

    Life Sciences, Vol. 80, Núm. 23, pp. 2108-2117

2006

  1. Phenylsulphonyl urenyl chalcone derivatives as dual inhibitors of cyclo-oxygenase-2 and 5-lipoxygenase

    Life Sciences, Vol. 78, Núm. 25, pp. 2911-2918

2004

  1. Role of nuclear factor-κB and heme oxygenase-1 in the mechanism of action of an anti-inflammatory chalcone derivative in RAW 264.7 cells

    British Journal of Pharmacology, Vol. 142, Núm. 7, pp. 1191-1199

2003

  1. Therapeutic administration of 3,4,5-trimethoxy-4′-fluorochalcone, a selective inhibitor of iNOS expression, attenuates the development of adjuvant-induced arthritis in rats

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 368, Núm. 3, pp. 225-233

  2. ttCH, a selective inhibitor of inducible nitric oxide synthase expression with antiarthritic properties

    European Journal of Pharmacology, Vol. 465, Núm. 1-2, pp. 183-189

2002

  1. Synthesis and inhibitory activity of dimethylamino-chalcone derivatives on the induction of nitric oxide synthase

    European Journal of Medicinal Chemistry, Vol. 37, Núm. 8, pp. 699-705

2001

  1. 4-Dimethylamino-3′,4′-dimethoxychalcone downregulates iNOS expression and exerts anti-inflammatory effects

    Free Radical Biology and Medicine, Vol. 30, Núm. 1, pp. 43-50

1999

  1. Novel anti-inflammatory chalcone derivatives inhibit the induction of nitric oxide synthase and cyclooxygenase-2 in mouse peritoneal macrophages

    FEBS Letters, Vol. 453, Núm. 1-2, pp. 129-134

1998

  1. Synthesis and anti-inflammatory activity of chalcone derivatives

    Bioorganic and Medicinal Chemistry Letters, Vol. 8, Núm. 10, pp. 1169-1174